Clinical Trial Update: Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes [Phase 1]

View source ↗

Summary

This clinical trial update reports safety data for liraglutide in pediatric patients with Type 2 diabetes (Phase 1; completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Victoza (Liraglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED